nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—prostate cancer—Hydrocortisone—ulcerative colitis	0.227	0.45	CpDpCtD
Fentanyl—ABCB1—ulcerative colitis	0.142	1	CbGaD
Fentanyl—prostate cancer—Dexamethasone—ulcerative colitis	0.138	0.275	CpDpCtD
Fentanyl—prostate cancer—Betamethasone—ulcerative colitis	0.138	0.275	CpDpCtD
Fentanyl—CYP3A4—Budesonide—ulcerative colitis	0.0185	0.0847	CbGbCtD
Fentanyl—CYP3A7—Hydrocortisone—ulcerative colitis	0.0172	0.0787	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Hydrocortisone—ulcerative colitis	0.0172	0.0787	CbGbCtD
Fentanyl—CYP3A5—Sulfasalazine—ulcerative colitis	0.016	0.0735	CbGbCtD
Fentanyl—ABCB1—Methylprednisolone—ulcerative colitis	0.0138	0.0632	CbGbCtD
Fentanyl—CYP3A5—Hydrocortisone—ulcerative colitis	0.0129	0.059	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Dexamethasone—ulcerative colitis	0.0107	0.0489	CbGbCtD
Fentanyl—CYP3A7—Dexamethasone—ulcerative colitis	0.0107	0.0489	CbGbCtD
Fentanyl—ABCB1—Betamethasone—ulcerative colitis	0.00896	0.0411	CbGbCtD
Fentanyl—ABCB1—Prednisolone—ulcerative colitis	0.00884	0.0405	CbGbCtD
Fentanyl—ABCB1—Hydrocortisone—ulcerative colitis	0.00838	0.0384	CbGbCtD
Fentanyl—ABCB1—Prednisone—ulcerative colitis	0.00835	0.0383	CbGbCtD
Fentanyl—CYP3A4—Methylprednisolone—ulcerative colitis	0.00825	0.0378	CbGbCtD
Fentanyl—CYP3A4—Nicotine—ulcerative colitis	0.00804	0.0369	CbGbCtD
Fentanyl—CYP3A5—Dexamethasone—ulcerative colitis	0.00801	0.0367	CbGbCtD
Fentanyl—CYP3A4—Cholecalciferol—ulcerative colitis	0.00721	0.0331	CbGbCtD
Fentanyl—CYP3A4—Triamcinolone—ulcerative colitis	0.00626	0.0287	CbGbCtD
Fentanyl—CYP3A4—Betamethasone—ulcerative colitis	0.00537	0.0246	CbGbCtD
Fentanyl—CYP3A4—Prednisolone—ulcerative colitis	0.0053	0.0243	CbGbCtD
Fentanyl—ABCB1—Dexamethasone—ulcerative colitis	0.00521	0.0239	CbGbCtD
Fentanyl—CYP3A4—Hydrocortisone—ulcerative colitis	0.00502	0.023	CbGbCtD
Fentanyl—CYP3A4—Prednisone—ulcerative colitis	0.005	0.0229	CbGbCtD
Fentanyl—CYP3A4—Dexamethasone—ulcerative colitis	0.00312	0.0143	CbGbCtD
Fentanyl—Aprindine—CALM3—ulcerative colitis	0.000705	0.242	CrCbGaD
Fentanyl—Bepridil—CALM3—ulcerative colitis	0.000436	0.15	CrCbGaD
Fentanyl—Loperamide—CALM3—ulcerative colitis	0.000386	0.132	CrCbGaD
Fentanyl—Phenoxybenzamine—CALM3—ulcerative colitis	0.000339	0.116	CrCbGaD
Fentanyl—Alfentanil—ALB—ulcerative colitis	0.000128	0.0439	CrCbGaD
Fentanyl—Alfentanil—ABCB1—ulcerative colitis	0.000122	0.0419	CrCbGaD
Fentanyl—Phenylbutazone—PTGS1—ulcerative colitis	0.00012	0.0412	CrCbGaD
Fentanyl—Diphenhydramine—SLC22A5—ulcerative colitis	0.00012	0.0412	CrCbGaD
Fentanyl—Astemizole—ABCB1—ulcerative colitis	9.5e-05	0.0326	CrCbGaD
Fentanyl—Phenoxybenzamine—ADRB2—ulcerative colitis	8.31e-05	0.0285	CrCbGaD
Fentanyl—Phenylbutazone—PTGS2—ulcerative colitis	6.87e-05	0.0236	CrCbGaD
Fentanyl—Fexofenadine—ABCB1—ulcerative colitis	6.77e-05	0.0232	CrCbGaD
Fentanyl—Diphenhydramine—PTGS1—ulcerative colitis	6.54e-05	0.0224	CrCbGaD
Fentanyl—Propafenone—ABCB1—ulcerative colitis	5.46e-05	0.0187	CrCbGaD
Fentanyl—Bepridil—ABCB1—ulcerative colitis	4.86e-05	0.0167	CrCbGaD
Fentanyl—Loperamide—ABCB1—ulcerative colitis	4.31e-05	0.0148	CrCbGaD
Fentanyl—Nervous system disorder—Hydrocortisone—ulcerative colitis	3.24e-05	0.000258	CcSEcCtD
Fentanyl—Myalgia—Methylprednisolone—ulcerative colitis	3.24e-05	0.000258	CcSEcCtD
Fentanyl—Arthralgia—Methylprednisolone—ulcerative colitis	3.24e-05	0.000258	CcSEcCtD
Fentanyl—Eye disorder—Prednisone—ulcerative colitis	3.23e-05	0.000258	CcSEcCtD
Fentanyl—Anxiety—Methylprednisolone—ulcerative colitis	3.22e-05	0.000257	CcSEcCtD
Fentanyl—Tachycardia—Hydrocortisone—ulcerative colitis	3.22e-05	0.000257	CcSEcCtD
Fentanyl—Rash—Azathioprine—ulcerative colitis	3.21e-05	0.000256	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	3.21e-05	0.000256	CcSEcCtD
Fentanyl—Dermatitis—Azathioprine—ulcerative colitis	3.21e-05	0.000256	CcSEcCtD
Fentanyl—Flushing—Prednisone—ulcerative colitis	3.21e-05	0.000256	CcSEcCtD
Fentanyl—Skin disorder—Hydrocortisone—ulcerative colitis	3.21e-05	0.000256	CcSEcCtD
Fentanyl—Ill-defined disorder—Dexamethasone—ulcerative colitis	3.21e-05	0.000256	CcSEcCtD
Fentanyl—Ill-defined disorder—Betamethasone—ulcerative colitis	3.21e-05	0.000256	CcSEcCtD
Fentanyl—Discomfort—Triamcinolone—ulcerative colitis	3.2e-05	0.000256	CcSEcCtD
Fentanyl—Discomfort—Methylprednisolone—ulcerative colitis	3.2e-05	0.000255	CcSEcCtD
Fentanyl—Headache—Azathioprine—ulcerative colitis	3.19e-05	0.000255	CcSEcCtD
Fentanyl—Hyperhidrosis—Hydrocortisone—ulcerative colitis	3.19e-05	0.000255	CcSEcCtD
Fentanyl—Diarrhoea—Mesalazine—ulcerative colitis	3.18e-05	0.000253	CcSEcCtD
Fentanyl—Dry mouth—Triamcinolone—ulcerative colitis	3.17e-05	0.000253	CcSEcCtD
Fentanyl—Anorexia—Hydrocortisone—ulcerative colitis	3.15e-05	0.000251	CcSEcCtD
Fentanyl—Angiopathy—Prednisone—ulcerative colitis	3.14e-05	0.00025	CcSEcCtD
Fentanyl—Confusional state—Methylprednisolone—ulcerative colitis	3.13e-05	0.000249	CcSEcCtD
Fentanyl—Immune system disorder—Prednisone—ulcerative colitis	3.12e-05	0.000249	CcSEcCtD
Fentanyl—Malaise—Dexamethasone—ulcerative colitis	3.12e-05	0.000249	CcSEcCtD
Fentanyl—Malaise—Betamethasone—ulcerative colitis	3.12e-05	0.000249	CcSEcCtD
Fentanyl—Oedema—Triamcinolone—ulcerative colitis	3.11e-05	0.000248	CcSEcCtD
Fentanyl—Anaphylactic shock—Triamcinolone—ulcerative colitis	3.11e-05	0.000248	CcSEcCtD
Fentanyl—Vertigo—Dexamethasone—ulcerative colitis	3.11e-05	0.000248	CcSEcCtD
Fentanyl—Vertigo—Betamethasone—ulcerative colitis	3.11e-05	0.000248	CcSEcCtD
Fentanyl—Anaphylactic shock—Methylprednisolone—ulcerative colitis	3.1e-05	0.000247	CcSEcCtD
Fentanyl—Syncope—Dexamethasone—ulcerative colitis	3.1e-05	0.000247	CcSEcCtD
Fentanyl—Syncope—Betamethasone—ulcerative colitis	3.1e-05	0.000247	CcSEcCtD
Fentanyl—Arrhythmia—Prednisone—ulcerative colitis	3.09e-05	0.000246	CcSEcCtD
Fentanyl—Infection—Triamcinolone—ulcerative colitis	3.09e-05	0.000246	CcSEcCtD
Fentanyl—Hypotension—Hydrocortisone—ulcerative colitis	3.09e-05	0.000246	CcSEcCtD
Fentanyl—Infection—Methylprednisolone—ulcerative colitis	3.08e-05	0.000246	CcSEcCtD
Fentanyl—Dizziness—Mesalazine—ulcerative colitis	3.07e-05	0.000245	CcSEcCtD
Fentanyl—Methadone—ABCB1—ulcerative colitis	3.07e-05	0.0105	CrCbGaD
Fentanyl—Shock—Triamcinolone—ulcerative colitis	3.06e-05	0.000244	CcSEcCtD
Fentanyl—Insomnia—Prednisolone—ulcerative colitis	3.06e-05	0.000244	CcSEcCtD
Fentanyl—Alopecia—Prednisone—ulcerative colitis	3.06e-05	0.000244	CcSEcCtD
Fentanyl—Shock—Methylprednisolone—ulcerative colitis	3.05e-05	0.000243	CcSEcCtD
Fentanyl—Nervous system disorder—Methylprednisolone—ulcerative colitis	3.04e-05	0.000243	CcSEcCtD
Fentanyl—Loss of consciousness—Dexamethasone—ulcerative colitis	3.04e-05	0.000242	CcSEcCtD
Fentanyl—Loss of consciousness—Betamethasone—ulcerative colitis	3.04e-05	0.000242	CcSEcCtD
Fentanyl—Paraesthesia—Prednisolone—ulcerative colitis	3.04e-05	0.000242	CcSEcCtD
Fentanyl—Tachycardia—Triamcinolone—ulcerative colitis	3.03e-05	0.000242	CcSEcCtD
Fentanyl—Mental disorder—Prednisone—ulcerative colitis	3.03e-05	0.000242	CcSEcCtD
Fentanyl—Nausea—Azathioprine—ulcerative colitis	3.03e-05	0.000241	CcSEcCtD
Fentanyl—Tachycardia—Methylprednisolone—ulcerative colitis	3.03e-05	0.000241	CcSEcCtD
Fentanyl—Skin disorder—Methylprednisolone—ulcerative colitis	3.01e-05	0.00024	CcSEcCtD
Fentanyl—Erythema—Prednisone—ulcerative colitis	3.01e-05	0.00024	CcSEcCtD
Fentanyl—Malnutrition—Prednisone—ulcerative colitis	3.01e-05	0.00024	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	3.01e-05	0.00024	CcSEcCtD
Fentanyl—Hyperhidrosis—Triamcinolone—ulcerative colitis	3.01e-05	0.00024	CcSEcCtD
Fentanyl—Hyperhidrosis—Methylprednisolone—ulcerative colitis	3e-05	0.000239	CcSEcCtD
Fentanyl—Convulsion—Betamethasone—ulcerative colitis	2.99e-05	0.000239	CcSEcCtD
Fentanyl—Convulsion—Dexamethasone—ulcerative colitis	2.99e-05	0.000239	CcSEcCtD
Fentanyl—Insomnia—Hydrocortisone—ulcerative colitis	2.99e-05	0.000238	CcSEcCtD
Fentanyl—Hypertension—Betamethasone—ulcerative colitis	2.98e-05	0.000238	CcSEcCtD
Fentanyl—Hypertension—Dexamethasone—ulcerative colitis	2.98e-05	0.000238	CcSEcCtD
Fentanyl—Paraesthesia—Hydrocortisone—ulcerative colitis	2.97e-05	0.000236	CcSEcCtD
Fentanyl—Vomiting—Mesalazine—ulcerative colitis	2.95e-05	0.000235	CcSEcCtD
Fentanyl—Myalgia—Betamethasone—ulcerative colitis	2.94e-05	0.000235	CcSEcCtD
Fentanyl—Myalgia—Dexamethasone—ulcerative colitis	2.94e-05	0.000235	CcSEcCtD
Fentanyl—Anxiety—Betamethasone—ulcerative colitis	2.93e-05	0.000234	CcSEcCtD
Fentanyl—Anxiety—Dexamethasone—ulcerative colitis	2.93e-05	0.000234	CcSEcCtD
Fentanyl—Rash—Mesalazine—ulcerative colitis	2.93e-05	0.000233	CcSEcCtD
Fentanyl—Dermatitis—Mesalazine—ulcerative colitis	2.93e-05	0.000233	CcSEcCtD
Fentanyl—Headache—Mesalazine—ulcerative colitis	2.91e-05	0.000232	CcSEcCtD
Fentanyl—Discomfort—Dexamethasone—ulcerative colitis	2.91e-05	0.000232	CcSEcCtD
Fentanyl—Discomfort—Betamethasone—ulcerative colitis	2.91e-05	0.000232	CcSEcCtD
Fentanyl—Dyspepsia—Hydrocortisone—ulcerative colitis	2.91e-05	0.000232	CcSEcCtD
Fentanyl—Hypotension—Methylprednisolone—ulcerative colitis	2.9e-05	0.000231	CcSEcCtD
Fentanyl—Pain—Prednisolone—ulcerative colitis	2.89e-05	0.000231	CcSEcCtD
Fentanyl—Decreased appetite—Hydrocortisone—ulcerative colitis	2.87e-05	0.000229	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	2.85e-05	0.000227	CcSEcCtD
Fentanyl—Fatigue—Hydrocortisone—ulcerative colitis	2.85e-05	0.000227	CcSEcCtD
Fentanyl—Vision blurred—Prednisone—ulcerative colitis	2.84e-05	0.000226	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	2.83e-05	0.000226	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	2.83e-05	0.000225	CcSEcCtD
Fentanyl—Pain—Hydrocortisone—ulcerative colitis	2.82e-05	0.000225	CcSEcCtD
Fentanyl—Oedema—Dexamethasone—ulcerative colitis	2.82e-05	0.000225	CcSEcCtD
Fentanyl—Oedema—Betamethasone—ulcerative colitis	2.82e-05	0.000225	CcSEcCtD
Fentanyl—Anaphylactic shock—Dexamethasone—ulcerative colitis	2.82e-05	0.000225	CcSEcCtD
Fentanyl—Anaphylactic shock—Betamethasone—ulcerative colitis	2.82e-05	0.000225	CcSEcCtD
Fentanyl—Insomnia—Triamcinolone—ulcerative colitis	2.81e-05	0.000224	CcSEcCtD
Fentanyl—Insomnia—Methylprednisolone—ulcerative colitis	2.81e-05	0.000224	CcSEcCtD
Fentanyl—Infection—Dexamethasone—ulcerative colitis	2.8e-05	0.000223	CcSEcCtD
Fentanyl—Infection—Betamethasone—ulcerative colitis	2.8e-05	0.000223	CcSEcCtD
Fentanyl—Ill-defined disorder—Prednisone—ulcerative colitis	2.79e-05	0.000223	CcSEcCtD
Fentanyl—Paraesthesia—Triamcinolone—ulcerative colitis	2.79e-05	0.000223	CcSEcCtD
Fentanyl—Feeling abnormal—Prednisolone—ulcerative colitis	2.79e-05	0.000222	CcSEcCtD
Fentanyl—Paraesthesia—Methylprednisolone—ulcerative colitis	2.79e-05	0.000222	CcSEcCtD
Fentanyl—Anaemia—Prednisone—ulcerative colitis	2.78e-05	0.000222	CcSEcCtD
Fentanyl—Shock—Betamethasone—ulcerative colitis	2.78e-05	0.000221	CcSEcCtD
Fentanyl—Shock—Dexamethasone—ulcerative colitis	2.78e-05	0.000221	CcSEcCtD
Fentanyl—Dyspnoea—Triamcinolone—ulcerative colitis	2.77e-05	0.000221	CcSEcCtD
Fentanyl—Nervous system disorder—Betamethasone—ulcerative colitis	2.77e-05	0.000221	CcSEcCtD
Fentanyl—Nervous system disorder—Dexamethasone—ulcerative colitis	2.77e-05	0.000221	CcSEcCtD
Fentanyl—Agitation—Prednisone—ulcerative colitis	2.77e-05	0.000221	CcSEcCtD
Fentanyl—Thrombocytopenia—Betamethasone—ulcerative colitis	2.76e-05	0.00022	CcSEcCtD
Fentanyl—Thrombocytopenia—Dexamethasone—ulcerative colitis	2.76e-05	0.00022	CcSEcCtD
Fentanyl—Nausea—Mesalazine—ulcerative colitis	2.76e-05	0.00022	CcSEcCtD
Fentanyl—Tachycardia—Dexamethasone—ulcerative colitis	2.75e-05	0.00022	CcSEcCtD
Fentanyl—Tachycardia—Betamethasone—ulcerative colitis	2.75e-05	0.00022	CcSEcCtD
Fentanyl—Dyspepsia—Triamcinolone—ulcerative colitis	2.74e-05	0.000218	CcSEcCtD
Fentanyl—Dyspepsia—Methylprednisolone—ulcerative colitis	2.73e-05	0.000218	CcSEcCtD
Fentanyl—Hyperhidrosis—Dexamethasone—ulcerative colitis	2.73e-05	0.000217	CcSEcCtD
Fentanyl—Hyperhidrosis—Betamethasone—ulcerative colitis	2.73e-05	0.000217	CcSEcCtD
Fentanyl—Feeling abnormal—Hydrocortisone—ulcerative colitis	2.72e-05	0.000217	CcSEcCtD
Fentanyl—Malaise—Prednisone—ulcerative colitis	2.71e-05	0.000216	CcSEcCtD
Fentanyl—Vertigo—Prednisone—ulcerative colitis	2.7e-05	0.000216	CcSEcCtD
Fentanyl—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	2.7e-05	0.000215	CcSEcCtD
Fentanyl—Syncope—Prednisone—ulcerative colitis	2.7e-05	0.000215	CcSEcCtD
Fentanyl—Anorexia—Betamethasone—ulcerative colitis	2.69e-05	0.000214	CcSEcCtD
Fentanyl—Anorexia—Dexamethasone—ulcerative colitis	2.69e-05	0.000214	CcSEcCtD
Fentanyl—Urticaria—Prednisolone—ulcerative colitis	2.69e-05	0.000214	CcSEcCtD
Fentanyl—Fatigue—Triamcinolone—ulcerative colitis	2.68e-05	0.000214	CcSEcCtD
Fentanyl—Fatigue—Methylprednisolone—ulcerative colitis	2.67e-05	0.000213	CcSEcCtD
Fentanyl—Pain—Triamcinolone—ulcerative colitis	2.66e-05	0.000212	CcSEcCtD
Fentanyl—Loss of consciousness—Prednisone—ulcerative colitis	2.65e-05	0.000211	CcSEcCtD
Fentanyl—Hypotension—Betamethasone—ulcerative colitis	2.64e-05	0.00021	CcSEcCtD
Fentanyl—Hypotension—Dexamethasone—ulcerative colitis	2.64e-05	0.00021	CcSEcCtD
Fentanyl—Urticaria—Hydrocortisone—ulcerative colitis	2.62e-05	0.000209	CcSEcCtD
Fentanyl—Abdominal pain—Hydrocortisone—ulcerative colitis	2.61e-05	0.000208	CcSEcCtD
Fentanyl—Body temperature increased—Hydrocortisone—ulcerative colitis	2.61e-05	0.000208	CcSEcCtD
Fentanyl—Convulsion—Prednisone—ulcerative colitis	2.61e-05	0.000208	CcSEcCtD
Fentanyl—Hypertension—Prednisone—ulcerative colitis	2.6e-05	0.000207	CcSEcCtD
Fentanyl—OPRD1—G alpha (i) signalling events—ADCY5—ulcerative colitis	2.58e-05	0.00339	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—CXCR2—ulcerative colitis	2.57e-05	0.00338	CbGpPWpGaD
Fentanyl—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	2.57e-05	0.000205	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	2.57e-05	0.000205	CcSEcCtD
Fentanyl—Myalgia—Prednisone—ulcerative colitis	2.56e-05	0.000204	CcSEcCtD
Fentanyl—Arthralgia—Prednisone—ulcerative colitis	2.56e-05	0.000204	CcSEcCtD
Fentanyl—Feeling abnormal—Triamcinolone—ulcerative colitis	2.56e-05	0.000204	CcSEcCtD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	2.56e-05	0.00336	CbGpPWpGaD
Fentanyl—Feeling abnormal—Methylprednisolone—ulcerative colitis	2.56e-05	0.000204	CcSEcCtD
Fentanyl—Anxiety—Prednisone—ulcerative colitis	2.55e-05	0.000204	CcSEcCtD
Fentanyl—Insomnia—Dexamethasone—ulcerative colitis	2.55e-05	0.000203	CcSEcCtD
Fentanyl—Insomnia—Betamethasone—ulcerative colitis	2.55e-05	0.000203	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	2.55e-05	0.000203	CcSEcCtD
Fentanyl—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	2.54e-05	0.000202	CcSEcCtD
Fentanyl—Paraesthesia—Dexamethasone—ulcerative colitis	2.53e-05	0.000202	CcSEcCtD
Fentanyl—Paraesthesia—Betamethasone—ulcerative colitis	2.53e-05	0.000202	CcSEcCtD
Fentanyl—Discomfort—Prednisone—ulcerative colitis	2.53e-05	0.000202	CcSEcCtD
Fentanyl—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	2.53e-05	0.00332	CbGpPWpGaD
Fentanyl—Hypersensitivity—Prednisolone—ulcerative colitis	2.49e-05	0.000199	CcSEcCtD
Fentanyl—OPRM1—TCR Signaling Pathway—RELA—ulcerative colitis	2.49e-05	0.00327	CbGpPWpGaD
Fentanyl—Dyspepsia—Dexamethasone—ulcerative colitis	2.48e-05	0.000198	CcSEcCtD
Fentanyl—Dyspepsia—Betamethasone—ulcerative colitis	2.48e-05	0.000198	CcSEcCtD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	2.47e-05	0.00325	CbGpPWpGaD
Fentanyl—Urticaria—Triamcinolone—ulcerative colitis	2.47e-05	0.000197	CcSEcCtD
Fentanyl—Urticaria—Methylprednisolone—ulcerative colitis	2.46e-05	0.000196	CcSEcCtD
Fentanyl—Body temperature increased—Triamcinolone—ulcerative colitis	2.46e-05	0.000196	CcSEcCtD
Fentanyl—Anaphylactic shock—Prednisone—ulcerative colitis	2.46e-05	0.000196	CcSEcCtD
Fentanyl—Oedema—Prednisone—ulcerative colitis	2.46e-05	0.000196	CcSEcCtD
Fentanyl—Abdominal pain—Methylprednisolone—ulcerative colitis	2.45e-05	0.000196	CcSEcCtD
Fentanyl—Decreased appetite—Dexamethasone—ulcerative colitis	2.45e-05	0.000196	CcSEcCtD
Fentanyl—Decreased appetite—Betamethasone—ulcerative colitis	2.45e-05	0.000196	CcSEcCtD
Fentanyl—Infection—Prednisone—ulcerative colitis	2.44e-05	0.000195	CcSEcCtD
Fentanyl—OPRM1—GPCR ligand binding—CCL20—ulcerative colitis	2.44e-05	0.00321	CbGpPWpGaD
Fentanyl—Gastrointestinal disorder—Betamethasone—ulcerative colitis	2.44e-05	0.000194	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	2.44e-05	0.000194	CcSEcCtD
Fentanyl—OPRM1—TCR Signaling Pathway—CD4—ulcerative colitis	2.43e-05	0.0032	CbGpPWpGaD
Fentanyl—Hypersensitivity—Hydrocortisone—ulcerative colitis	2.43e-05	0.000194	CcSEcCtD
Fentanyl—Fatigue—Dexamethasone—ulcerative colitis	2.43e-05	0.000194	CcSEcCtD
Fentanyl—Fatigue—Betamethasone—ulcerative colitis	2.43e-05	0.000194	CcSEcCtD
Fentanyl—OPRD1—GPCR ligand binding—PTGER4—ulcerative colitis	2.43e-05	0.00319	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—CCR6—ulcerative colitis	2.42e-05	0.00318	CbGpPWpGaD
Fentanyl—Shock—Prednisone—ulcerative colitis	2.42e-05	0.000193	CcSEcCtD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	2.42e-05	0.00318	CbGpPWpGaD
Fentanyl—Pain—Dexamethasone—ulcerative colitis	2.41e-05	0.000192	CcSEcCtD
Fentanyl—Pain—Betamethasone—ulcerative colitis	2.41e-05	0.000192	CcSEcCtD
Fentanyl—Nervous system disorder—Prednisone—ulcerative colitis	2.41e-05	0.000192	CcSEcCtD
Fentanyl—Tachycardia—Prednisone—ulcerative colitis	2.4e-05	0.000191	CcSEcCtD
Fentanyl—Skin disorder—Prednisone—ulcerative colitis	2.39e-05	0.00019	CcSEcCtD
Fentanyl—Hyperhidrosis—Prednisone—ulcerative colitis	2.38e-05	0.000189	CcSEcCtD
Fentanyl—Asthenia—Hydrocortisone—ulcerative colitis	2.37e-05	0.000189	CcSEcCtD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	2.36e-05	0.00311	CbGpPWpGaD
Fentanyl—Anorexia—Prednisone—ulcerative colitis	2.34e-05	0.000187	CcSEcCtD
Fentanyl—Pruritus—Hydrocortisone—ulcerative colitis	2.34e-05	0.000186	CcSEcCtD
Fentanyl—CYP3A5—Biological oxidations—PTGS1—ulcerative colitis	2.33e-05	0.00307	CbGpPWpGaD
Fentanyl—Feeling abnormal—Dexamethasone—ulcerative colitis	2.32e-05	0.000185	CcSEcCtD
Fentanyl—Feeling abnormal—Betamethasone—ulcerative colitis	2.32e-05	0.000185	CcSEcCtD
Fentanyl—Gastrointestinal pain—Dexamethasone—ulcerative colitis	2.31e-05	0.000184	CcSEcCtD
Fentanyl—Gastrointestinal pain—Betamethasone—ulcerative colitis	2.31e-05	0.000184	CcSEcCtD
Fentanyl—Hypersensitivity—Triamcinolone—ulcerative colitis	2.29e-05	0.000183	CcSEcCtD
Fentanyl—Hypersensitivity—Methylprednisolone—ulcerative colitis	2.29e-05	0.000182	CcSEcCtD
Fentanyl—OPRK1—G alpha (i) signalling events—ADCY5—ulcerative colitis	2.26e-05	0.00297	CbGpPWpGaD
Fentanyl—Diarrhoea—Hydrocortisone—ulcerative colitis	2.26e-05	0.00018	CcSEcCtD
Fentanyl—OPRM1—TCR Signaling Pathway—IL1B—ulcerative colitis	2.25e-05	0.00296	CbGpPWpGaD
Fentanyl—Urticaria—Betamethasone—ulcerative colitis	2.24e-05	0.000179	CcSEcCtD
Fentanyl—Urticaria—Dexamethasone—ulcerative colitis	2.24e-05	0.000179	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Prednisone—ulcerative colitis	2.24e-05	0.000178	CcSEcCtD
Fentanyl—Dizziness—Prednisolone—ulcerative colitis	2.24e-05	0.000178	CcSEcCtD
Fentanyl—ABCB1—Allograft Rejection—IL10—ulcerative colitis	2.23e-05	0.00293	CbGpPWpGaD
Fentanyl—Asthenia—Triamcinolone—ulcerative colitis	2.23e-05	0.000178	CcSEcCtD
Fentanyl—Body temperature increased—Dexamethasone—ulcerative colitis	2.23e-05	0.000178	CcSEcCtD
Fentanyl—Body temperature increased—Betamethasone—ulcerative colitis	2.23e-05	0.000178	CcSEcCtD
Fentanyl—Abdominal pain—Betamethasone—ulcerative colitis	2.23e-05	0.000178	CcSEcCtD
Fentanyl—Abdominal pain—Dexamethasone—ulcerative colitis	2.23e-05	0.000178	CcSEcCtD
Fentanyl—Asthenia—Methylprednisolone—ulcerative colitis	2.23e-05	0.000177	CcSEcCtD
Fentanyl—Insomnia—Prednisone—ulcerative colitis	2.22e-05	0.000177	CcSEcCtD
Fentanyl—OPRD1—GPCR ligand binding—GHRL—ulcerative colitis	2.22e-05	0.00292	CbGpPWpGaD
Fentanyl—Paraesthesia—Prednisone—ulcerative colitis	2.21e-05	0.000176	CcSEcCtD
Fentanyl—Pruritus—Triamcinolone—ulcerative colitis	2.2e-05	0.000175	CcSEcCtD
Fentanyl—Pruritus—Methylprednisolone—ulcerative colitis	2.19e-05	0.000175	CcSEcCtD
Fentanyl—Dizziness—Hydrocortisone—ulcerative colitis	2.18e-05	0.000174	CcSEcCtD
Fentanyl—OPRM1—GPCR ligand binding—CXCR2—ulcerative colitis	2.17e-05	0.00286	CbGpPWpGaD
Fentanyl—Dyspepsia—Prednisone—ulcerative colitis	2.16e-05	0.000172	CcSEcCtD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	2.16e-05	0.00284	CbGpPWpGaD
Fentanyl—Decreased appetite—Prednisone—ulcerative colitis	2.14e-05	0.00017	CcSEcCtD
Fentanyl—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	2.13e-05	0.0028	CbGpPWpGaD
Fentanyl—Rash—Prednisolone—ulcerative colitis	2.13e-05	0.00017	CcSEcCtD
Fentanyl—Dermatitis—Prednisolone—ulcerative colitis	2.13e-05	0.00017	CcSEcCtD
Fentanyl—OPRK1—GPCR ligand binding—PTGER4—ulcerative colitis	2.13e-05	0.0028	CbGpPWpGaD
Fentanyl—Diarrhoea—Methylprednisolone—ulcerative colitis	2.12e-05	0.000169	CcSEcCtD
Fentanyl—Fatigue—Prednisone—ulcerative colitis	2.12e-05	0.000169	CcSEcCtD
Fentanyl—Headache—Prednisolone—ulcerative colitis	2.12e-05	0.000169	CcSEcCtD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	2.12e-05	0.00279	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CXCR1—ulcerative colitis	2.12e-05	0.00278	CbGpPWpGaD
Fentanyl—Constipation—Prednisone—ulcerative colitis	2.1e-05	0.000168	CcSEcCtD
Fentanyl—Vomiting—Hydrocortisone—ulcerative colitis	2.1e-05	0.000167	CcSEcCtD
Fentanyl—OPRM1—TCR Signaling Pathway—NFKB1—ulcerative colitis	2.1e-05	0.00276	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	2.09e-05	0.00275	CbGpPWpGaD
Fentanyl—Rash—Hydrocortisone—ulcerative colitis	2.08e-05	0.000166	CcSEcCtD
Fentanyl—Dermatitis—Hydrocortisone—ulcerative colitis	2.08e-05	0.000166	CcSEcCtD
Fentanyl—Headache—Hydrocortisone—ulcerative colitis	2.07e-05	0.000165	CcSEcCtD
Fentanyl—Dizziness—Triamcinolone—ulcerative colitis	2.06e-05	0.000164	CcSEcCtD
Fentanyl—Dizziness—Methylprednisolone—ulcerative colitis	2.05e-05	0.000164	CcSEcCtD
Fentanyl—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	2.04e-05	0.00269	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—CCR6—ulcerative colitis	2.04e-05	0.00269	CbGpPWpGaD
Fentanyl—Feeling abnormal—Prednisone—ulcerative colitis	2.02e-05	0.000161	CcSEcCtD
Fentanyl—Asthenia—Dexamethasone—ulcerative colitis	2.02e-05	0.000161	CcSEcCtD
Fentanyl—Asthenia—Betamethasone—ulcerative colitis	2.02e-05	0.000161	CcSEcCtD
Fentanyl—Gastrointestinal pain—Prednisone—ulcerative colitis	2.01e-05	0.00016	CcSEcCtD
Fentanyl—Nausea—Prednisolone—ulcerative colitis	2.01e-05	0.00016	CcSEcCtD
Fentanyl—Pruritus—Betamethasone—ulcerative colitis	2e-05	0.000159	CcSEcCtD
Fentanyl—Pruritus—Dexamethasone—ulcerative colitis	2e-05	0.000159	CcSEcCtD
Fentanyl—Vomiting—Triamcinolone—ulcerative colitis	1.98e-05	0.000158	CcSEcCtD
Fentanyl—Vomiting—Methylprednisolone—ulcerative colitis	1.97e-05	0.000157	CcSEcCtD
Fentanyl—Nausea—Hydrocortisone—ulcerative colitis	1.96e-05	0.000156	CcSEcCtD
Fentanyl—Rash—Triamcinolone—ulcerative colitis	1.96e-05	0.000156	CcSEcCtD
Fentanyl—Dermatitis—Triamcinolone—ulcerative colitis	1.96e-05	0.000156	CcSEcCtD
Fentanyl—Rash—Methylprednisolone—ulcerative colitis	1.96e-05	0.000156	CcSEcCtD
Fentanyl—Dermatitis—Methylprednisolone—ulcerative colitis	1.95e-05	0.000156	CcSEcCtD
Fentanyl—Urticaria—Prednisone—ulcerative colitis	1.95e-05	0.000156	CcSEcCtD
Fentanyl—OPRK1—GPCR ligand binding—GHRL—ulcerative colitis	1.95e-05	0.00256	CbGpPWpGaD
Fentanyl—Headache—Triamcinolone—ulcerative colitis	1.95e-05	0.000155	CcSEcCtD
Fentanyl—Headache—Methylprednisolone—ulcerative colitis	1.94e-05	0.000155	CcSEcCtD
Fentanyl—Body temperature increased—Prednisone—ulcerative colitis	1.94e-05	0.000155	CcSEcCtD
Fentanyl—Abdominal pain—Prednisone—ulcerative colitis	1.94e-05	0.000155	CcSEcCtD
Fentanyl—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	1.93e-05	0.00254	CbGpPWpGaD
Fentanyl—Diarrhoea—Betamethasone—ulcerative colitis	1.93e-05	0.000154	CcSEcCtD
Fentanyl—Diarrhoea—Dexamethasone—ulcerative colitis	1.93e-05	0.000154	CcSEcCtD
Fentanyl—OPRD1—Signaling by GPCR—CXCR1—ulcerative colitis	1.92e-05	0.00253	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—ADCY5—ulcerative colitis	1.91e-05	0.00251	CbGpPWpGaD
Fentanyl—Dizziness—Betamethasone—ulcerative colitis	1.87e-05	0.000149	CcSEcCtD
Fentanyl—Dizziness—Dexamethasone—ulcerative colitis	1.87e-05	0.000149	CcSEcCtD
Fentanyl—OPRD1—GPCR downstream signaling—CCL20—ulcerative colitis	1.86e-05	0.00244	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CXCR1—ulcerative colitis	1.86e-05	0.00244	CbGpPWpGaD
Fentanyl—Nausea—Triamcinolone—ulcerative colitis	1.85e-05	0.000147	CcSEcCtD
Fentanyl—Nausea—Methylprednisolone—ulcerative colitis	1.84e-05	0.000147	CcSEcCtD
Fentanyl—OPRD1—GPCR ligand binding—ADRB2—ulcerative colitis	1.84e-05	0.00242	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	1.82e-05	0.00239	CbGpPWpGaD
Fentanyl—Hypersensitivity—Prednisone—ulcerative colitis	1.81e-05	0.000144	CcSEcCtD
Fentanyl—OPRM1—GPCR ligand binding—PTGER4—ulcerative colitis	1.8e-05	0.00237	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	1.8e-05	0.00236	CbGpPWpGaD
Fentanyl—Vomiting—Dexamethasone—ulcerative colitis	1.79e-05	0.000143	CcSEcCtD
Fentanyl—Vomiting—Betamethasone—ulcerative colitis	1.79e-05	0.000143	CcSEcCtD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	1.79e-05	0.00235	CbGpPWpGaD
Fentanyl—Rash—Betamethasone—ulcerative colitis	1.78e-05	0.000142	CcSEcCtD
Fentanyl—Rash—Dexamethasone—ulcerative colitis	1.78e-05	0.000142	CcSEcCtD
Fentanyl—Dermatitis—Dexamethasone—ulcerative colitis	1.78e-05	0.000142	CcSEcCtD
Fentanyl—Dermatitis—Betamethasone—ulcerative colitis	1.78e-05	0.000142	CcSEcCtD
Fentanyl—Headache—Dexamethasone—ulcerative colitis	1.77e-05	0.000141	CcSEcCtD
Fentanyl—Headache—Betamethasone—ulcerative colitis	1.77e-05	0.000141	CcSEcCtD
Fentanyl—Asthenia—Prednisone—ulcerative colitis	1.76e-05	0.000141	CcSEcCtD
Fentanyl—OPRD1—GPCR downstream signaling—GNA12—ulcerative colitis	1.75e-05	0.0023	CbGpPWpGaD
Fentanyl—OPRM1—TCR Signaling Pathway—TGFB1—ulcerative colitis	1.75e-05	0.0023	CbGpPWpGaD
Fentanyl—OPRD1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	1.74e-05	0.00229	CbGpPWpGaD
Fentanyl—Pruritus—Prednisone—ulcerative colitis	1.74e-05	0.000139	CcSEcCtD
Fentanyl—OPRD1—Signaling by GPCR—CCL20—ulcerative colitis	1.69e-05	0.00222	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CXCR1—ulcerative colitis	1.69e-05	0.00222	CbGpPWpGaD
Fentanyl—Diarrhoea—Prednisone—ulcerative colitis	1.68e-05	0.000134	CcSEcCtD
Fentanyl—Nausea—Dexamethasone—ulcerative colitis	1.68e-05	0.000134	CcSEcCtD
Fentanyl—Nausea—Betamethasone—ulcerative colitis	1.68e-05	0.000134	CcSEcCtD
Fentanyl—OPRD1—GPCR downstream signaling—CXCR2—ulcerative colitis	1.66e-05	0.00218	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—GHRL—ulcerative colitis	1.65e-05	0.00217	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CCL20—ulcerative colitis	1.63e-05	0.00214	CbGpPWpGaD
Fentanyl—Dizziness—Prednisone—ulcerative colitis	1.62e-05	0.00013	CcSEcCtD
Fentanyl—OPRK1—GPCR ligand binding—ADRB2—ulcerative colitis	1.61e-05	0.00212	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—GNA12—ulcerative colitis	1.59e-05	0.00209	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CXCR1—ulcerative colitis	1.57e-05	0.00206	CbGpPWpGaD
Fentanyl—Vomiting—Prednisone—ulcerative colitis	1.56e-05	0.000125	CcSEcCtD
Fentanyl—OPRD1—GPCR downstream signaling—CCR6—ulcerative colitis	1.56e-05	0.00205	CbGpPWpGaD
Fentanyl—Rash—Prednisone—ulcerative colitis	1.55e-05	0.000124	CcSEcCtD
Fentanyl—Dermatitis—Prednisone—ulcerative colitis	1.55e-05	0.000123	CcSEcCtD
Fentanyl—Headache—Prednisone—ulcerative colitis	1.54e-05	0.000123	CcSEcCtD
Fentanyl—OPRK1—GPCR downstream signaling—GNA12—ulcerative colitis	1.53e-05	0.00202	CbGpPWpGaD
Fentanyl—OPRK1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	1.52e-05	0.00201	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CXCR2—ulcerative colitis	1.5e-05	0.00198	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CCL20—ulcerative colitis	1.48e-05	0.00195	CbGpPWpGaD
Fentanyl—OPRD1—G alpha (i) signalling events—CXCL8—ulcerative colitis	1.47e-05	0.00193	CbGpPWpGaD
Fentanyl—Nausea—Prednisone—ulcerative colitis	1.46e-05	0.000116	CcSEcCtD
Fentanyl—OPRK1—GPCR downstream signaling—CXCR2—ulcerative colitis	1.45e-05	0.00191	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CXCR1—ulcerative colitis	1.43e-05	0.00187	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CCR6—ulcerative colitis	1.41e-05	0.00186	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—GNA12—ulcerative colitis	1.39e-05	0.00183	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SEL1L—ulcerative colitis	1.38e-05	0.00181	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CCL20—ulcerative colitis	1.38e-05	0.00181	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—PTGER4—ulcerative colitis	1.37e-05	0.0018	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CCR6—ulcerative colitis	1.37e-05	0.0018	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—ADRB2—ulcerative colitis	1.36e-05	0.00179	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CHP1—ulcerative colitis	1.32e-05	0.00174	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CXCR2—ulcerative colitis	1.32e-05	0.00174	CbGpPWpGaD
Fentanyl—OPRM1—TCR Signaling Pathway—IL6—ulcerative colitis	1.32e-05	0.00173	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	1.31e-05	0.00173	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—GNA12—ulcerative colitis	1.3e-05	0.0017	CbGpPWpGaD
Fentanyl—OPRM1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	1.29e-05	0.00169	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—CXCL8—ulcerative colitis	1.29e-05	0.00169	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	1.26e-05	0.00165	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	1.26e-05	0.00165	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—GHRL—ulcerative colitis	1.26e-05	0.00165	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CCL20—ulcerative colitis	1.25e-05	0.00165	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PTGER4—ulcerative colitis	1.25e-05	0.00164	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CCR6—ulcerative colitis	1.24e-05	0.00163	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CXCR2—ulcerative colitis	1.23e-05	0.00161	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	1.22e-05	0.0016	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SEL1L—ulcerative colitis	1.21e-05	0.00159	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PTGER4—ulcerative colitis	1.2e-05	0.00158	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—GNA12—ulcerative colitis	1.18e-05	0.00155	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	1.17e-05	0.00154	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	1.17e-05	0.00153	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IL2—ulcerative colitis	1.17e-05	0.00153	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CCR6—ulcerative colitis	1.15e-05	0.00152	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—DLD—ulcerative colitis	1.14e-05	0.0015	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—GHRL—ulcerative colitis	1.14e-05	0.0015	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCR1—ulcerative colitis	1.14e-05	0.00149	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CXCR2—ulcerative colitis	1.12e-05	0.00147	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CALM3—ulcerative colitis	1.1e-05	0.00145	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—GHRL—ulcerative colitis	1.1e-05	0.00145	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PTGER4—ulcerative colitis	1.09e-05	0.00144	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—CXCL8—ulcerative colitis	1.09e-05	0.00143	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	1.09e-05	0.00143	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CCR6—ulcerative colitis	1.05e-05	0.00138	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—ADRB2—ulcerative colitis	1.04e-05	0.00137	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	1.02e-05	0.00135	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SEL1L—ulcerative colitis	1.02e-05	0.00134	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PTGER4—ulcerative colitis	1.02e-05	0.00134	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—GHRL—ulcerative colitis	1e-05	0.00131	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCL20—ulcerative colitis	9.97e-06	0.00131	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCR1—ulcerative colitis	9.96e-06	0.00131	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CALM3—ulcerative colitis	9.68e-06	0.00127	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CHP1—ulcerative colitis	9.57e-06	0.00126	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—ADRB2—ulcerative colitis	9.44e-06	0.00124	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GNA12—ulcerative colitis	9.38e-06	0.00123	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—GHRL—ulcerative colitis	9.31e-06	0.00122	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PTGER4—ulcerative colitis	9.23e-06	0.00121	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—ADRB2—ulcerative colitis	9.11e-06	0.0012	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	9.1e-06	0.0012	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCR2—ulcerative colitis	8.89e-06	0.00117	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—CXCL8—ulcerative colitis	8.88e-06	0.00117	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—ADCY5—ulcerative colitis	8.82e-06	0.00116	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCL20—ulcerative colitis	8.74e-06	0.00115	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	8.65e-06	0.00114	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—TNF—ulcerative colitis	8.49e-06	0.00112	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—GHRL—ulcerative colitis	8.45e-06	0.00111	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCR1—ulcerative colitis	8.42e-06	0.00111	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCR6—ulcerative colitis	8.36e-06	0.0011	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—ADRB2—ulcerative colitis	8.28e-06	0.00109	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—DLD—ulcerative colitis	8.26e-06	0.00109	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GNA12—ulcerative colitis	8.22e-06	0.00108	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CALM3—ulcerative colitis	8.18e-06	0.00108	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—ADCY5—ulcerative colitis	8.01e-06	0.00105	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAML2—ulcerative colitis	7.92e-06	0.00104	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	7.83e-06	0.00103	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCR2—ulcerative colitis	7.79e-06	0.00102	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—CXCL8—ulcerative colitis	7.79e-06	0.00102	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—ADCY5—ulcerative colitis	7.74e-06	0.00102	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—ADRB2—ulcerative colitis	7.7e-06	0.00101	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCL20—ulcerative colitis	7.39e-06	0.000972	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PTGER4—ulcerative colitis	7.36e-06	0.000968	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCR6—ulcerative colitis	7.33e-06	0.000964	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CHP1—ulcerative colitis	7.22e-06	0.000949	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—ADCY5—ulcerative colitis	7.03e-06	0.000924	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—ADRB2—ulcerative colitis	7e-06	0.00092	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GNA12—ulcerative colitis	6.95e-06	0.000914	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAML2—ulcerative colitis	6.95e-06	0.000914	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GHRL—ulcerative colitis	6.74e-06	0.000886	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCR2—ulcerative colitis	6.59e-06	0.000866	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—CXCL8—ulcerative colitis	6.58e-06	0.000866	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—ADCY5—ulcerative colitis	6.54e-06	0.00086	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CALM3—ulcerative colitis	6.52e-06	0.000858	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PTGER4—ulcerative colitis	6.45e-06	0.000848	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RIPK2—ulcerative colitis	6.43e-06	0.000845	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—DLD—ulcerative colitis	6.23e-06	0.000819	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	6.21e-06	0.000816	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCR6—ulcerative colitis	6.19e-06	0.000814	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—ADCY5—ulcerative colitis	5.94e-06	0.000781	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GHRL—ulcerative colitis	5.91e-06	0.000777	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAML2—ulcerative colitis	5.87e-06	0.000772	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CALM3—ulcerative colitis	5.72e-06	0.000752	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RIPK2—ulcerative colitis	5.64e-06	0.000741	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ADRB2—ulcerative colitis	5.58e-06	0.000733	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS1—ulcerative colitis	5.52e-06	0.000726	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—JAK2—ulcerative colitis	5.5e-06	0.000723	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PTGER4—ulcerative colitis	5.45e-06	0.000717	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	5.39e-06	0.000709	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CXCL8—ulcerative colitis	5.02e-06	0.00066	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—JAK2—ulcerative colitis	4.99e-06	0.000657	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GHRL—ulcerative colitis	4.99e-06	0.000656	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CALM3—ulcerative colitis	4.97e-06	0.000654	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ADRB2—ulcerative colitis	4.89e-06	0.000643	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CALM3—ulcerative colitis	4.83e-06	0.000636	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—JAK2—ulcerative colitis	4.82e-06	0.000634	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—IL2—ulcerative colitis	4.8e-06	0.000631	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RIPK2—ulcerative colitis	4.76e-06	0.000626	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ADCY5—ulcerative colitis	4.73e-06	0.000622	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CXCL8—ulcerative colitis	4.56e-06	0.000599	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	4.49e-06	0.00059	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CHP1—ulcerative colitis	4.45e-06	0.000585	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CXCL8—ulcerative colitis	4.4e-06	0.000579	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—JAK2—ulcerative colitis	4.38e-06	0.000576	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL2—ulcerative colitis	4.36e-06	0.000573	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—IL2—ulcerative colitis	4.21e-06	0.000553	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	4.2e-06	0.000553	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	4.19e-06	0.000551	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ADCY5—ulcerative colitis	4.15e-06	0.000546	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ADRB2—ulcerative colitis	4.13e-06	0.000543	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—JAK2—ulcerative colitis	4.08e-06	0.000536	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CXCL8—ulcerative colitis	4e-06	0.000526	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS1—ulcerative colitis	3.99e-06	0.000525	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ABCB1—ulcerative colitis	3.87e-06	0.000509	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—DLD—ulcerative colitis	3.84e-06	0.000505	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL2—ulcerative colitis	3.82e-06	0.000502	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CXCL8—ulcerative colitis	3.72e-06	0.000489	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—JAK2—ulcerative colitis	3.7e-06	0.000487	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	3.7e-06	0.000486	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ADCY5—ulcerative colitis	3.61e-06	0.000474	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CALM3—ulcerative colitis	3.59e-06	0.000473	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—IL2—ulcerative colitis	3.56e-06	0.000468	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ADCY5—ulcerative colitis	3.51e-06	0.000461	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CXCL8—ulcerative colitis	3.38e-06	0.000444	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL2—ulcerative colitis	3.23e-06	0.000425	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS1—ulcerative colitis	3.01e-06	0.000396	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—JAK2—ulcerative colitis	2.95e-06	0.000388	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RELA—ulcerative colitis	2.86e-06	0.000376	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.82e-06	0.000371	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ABCB1—ulcerative colitis	2.8e-06	0.000368	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CALM3—ulcerative colitis	2.71e-06	0.000357	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCL8—ulcerative colitis	2.69e-06	0.000354	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPARG—ulcerative colitis	2.69e-06	0.000354	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ADCY5—ulcerative colitis	2.61e-06	0.000343	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—JAK2—ulcerative colitis	2.59e-06	0.00034	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL2—ulcerative colitis	2.57e-06	0.000338	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6—ulcerative colitis	2.56e-06	0.000337	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RELA—ulcerative colitis	2.51e-06	0.00033	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MMP9—ulcerative colitis	2.44e-06	0.00032	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ALB—ulcerative colitis	2.42e-06	0.000318	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NFKB1—ulcerative colitis	2.41e-06	0.000317	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCL8—ulcerative colitis	2.36e-06	0.000311	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL2—ulcerative colitis	2.26e-06	0.000297	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6—ulcerative colitis	2.25e-06	0.000295	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—JAK2—ulcerative colitis	2.19e-06	0.000288	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—STAT3—ulcerative colitis	2.17e-06	0.000285	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MMP9—ulcerative colitis	2.14e-06	0.000281	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RELA—ulcerative colitis	2.12e-06	0.000278	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS2—ulcerative colitis	2.12e-06	0.000278	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NFKB1—ulcerative colitis	2.11e-06	0.000278	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TGFB1—ulcerative colitis	2.01e-06	0.000264	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCL8—ulcerative colitis	2e-06	0.000262	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ADCY5—ulcerative colitis	1.97e-06	0.000259	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARG—ulcerative colitis	1.94e-06	0.000256	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL2—ulcerative colitis	1.91e-06	0.000251	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—STAT3—ulcerative colitis	1.9e-06	0.00025	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6—ulcerative colitis	1.9e-06	0.00025	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.86e-06	0.000244	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MMP9—ulcerative colitis	1.81e-06	0.000237	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NFKB1—ulcerative colitis	1.79e-06	0.000235	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TGFB1—ulcerative colitis	1.76e-06	0.000231	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ALB—ulcerative colitis	1.75e-06	0.00023	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.67e-06	0.00022	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TP53—ulcerative colitis	1.65e-06	0.000217	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—STAT3—ulcerative colitis	1.61e-06	0.000211	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS2—ulcerative colitis	1.53e-06	0.000201	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6—ulcerative colitis	1.51e-06	0.000199	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TGFB1—ulcerative colitis	1.49e-06	0.000196	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARG—ulcerative colitis	1.47e-06	0.000193	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TP53—ulcerative colitis	1.45e-06	0.000191	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6—ulcerative colitis	1.33e-06	0.000174	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALB—ulcerative colitis	1.32e-06	0.000174	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.3e-06	0.000171	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TP53—ulcerative colitis	1.22e-06	0.000161	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.21e-06	0.000159	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS2—ulcerative colitis	1.15e-06	0.000152	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6—ulcerative colitis	1.12e-06	0.000147	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARG—ulcerative colitis	9.04e-07	0.000119	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALB—ulcerative colitis	8.13e-07	0.000107	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS2—ulcerative colitis	7.11e-07	9.35e-05	CbGpPWpGaD
